These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2189621)

  • 1. The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis.
    Chobanian AV
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII43-8. PubMed ID: 2189621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE-inhibitors and atherosclerosis.
    Ambrosioni E; Bacchelli S; Degli Esposti D; Borghi C
    Eur J Epidemiol; 1992 May; 8 Suppl 1():129-33. PubMed ID: 1324185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
    Chobanian AV; Haudenschild CC; Nickerson C; Drago R
    Hypertension; 1990 Mar; 15(3):327-31. PubMed ID: 2406202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit.
    Chobanian AV; Hope S; Brecher P
    Hypertension; 1995 Jun; 25(6):1306-10. PubMed ID: 7768578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits.
    Napoli C; Cicala C; D'Armiento FP; Roviezzo F; Somma P; de Nigris F; Zuliani P; Bucci M; Aleotti L; Casini A; Franconi F; Cirino G
    Gen Pharmacol; 1999 Dec; 33(6):467-77. PubMed ID: 10647772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Chobanian AV; Haudenschild CC; Nickerson C; Hope S
    Hypertension; 1992 Oct; 20(4):473-7. PubMed ID: 1398882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
    Sun YP; Zhu BQ; Browne AE; Pulukurthy S; Chou TM; Sudhir K; Glantz SA; Deedwania PC; Chatterjee K; Parmley WW
    J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):175-81. PubMed ID: 11509924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit.
    Chobanian AV; Lichtenstein AH; Nilakhe V; Haudenschild CC; Drago R; Nickerson C
    Hypertension; 1989 Aug; 14(2):203-9. PubMed ID: 2759679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic aortic coarctation on atherosclerosis and arterial lipid accumulation in the Watanabe hereditary hyperlipidemic (WHHL) rabbit.
    Roux SP; Kuhn H; Lengsfeld H; Morand OH
    Atherosclerosis; 1992 Mar; 93(1-2):123-32. PubMed ID: 1596295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
    Tilton GD; Buja LM; Bilheimer DW; Apprill P; Ashton J; McNatt J; Kita T; Willerson JT
    J Am Coll Cardiol; 1985 Jul; 6(1):141-4. PubMed ID: 4008771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic approaches to the differentiated drug therapy of hypertension].
    Malaia LT; Vasyl'iev IuM; Babadzhan VD; Koval' SN
    Lik Sprava; 1997; (3):47-51. PubMed ID: 9377352
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril.
    Kowala MC; Valentine M; Recce R; Beyer S; Goller N; Durham S; Aberg G
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):29-38. PubMed ID: 9676717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors and atherosclerosis.
    Andersson RG; Jacobsson L; Persson K
    J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
    Jacobsson LS; Persson K; Aberg G; Andersson RG; Karlberg BE; Olsson AG
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):670-7. PubMed ID: 7528851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.